Evidence map›Paper›PMID 39131600›Full record

ArticleJournal of asthma and allergy2024

Impact of Utilizing a Composite versus a Symptom-Only Validation Standard in the Development of the Asthma Impairment and Risk Questionnaire.

Bradley E Chipps, Robert S Zeiger, David A Beuther, Robert A Wise, William McCann, Joan Reibman, Maureen George, Ileen Gilbert, James M Eudicone, Karin S Coyne and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of asthma and allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bradley E ChippsCapital Allergy & Respiratory Disease Center, Sacramento, CA, USA.
Robert S ZeigerDepartment of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
David A BeutherDepartment of Medicine, National Jewish Health, Denver, CO, USA.ORCID 0000-0002-5021-5734
Robert A WiseDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-8353-2349
William McCannAllergy Partners, Asheville, NC, USA.
Joan ReibmanDepartment of Medicine, New York University School of Medicine, New York, NY, USA.
Maureen GeorgeColumbia University School of Nursing, New York, NY, USA.ORCID 0000-0001-9234-7842
Ileen GilbertBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.ORCID 0000-0003-3529-0186
James M EudiconeBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.ORCID 0000-0001-7020-2490
Karin S CoyneEvidera, Bethesda, MD, USA.
Gale HardingEvidera, Bethesda, MD, USA.
Kevin R MurphyBoys Town National Research Hospital, Boys Town, NE, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39131600
PMCPMC11317051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.